Literature DB >> 35510549

Perspectives on Cognitive Phenotypes and Models of Vascular Disease.

Selen C Muratoglu1, Marc F Charette1, Stacey J Sukoff Rizzo2, M Luisa Iruela-Arispe3, Zorina S Galis1, Adam S Greenstein4, Alan Daugherty5, Anne Joutel6, Beth A Kozel7, Donna M Wilcock8, Emily C Collins9, Farzaneh A Sorond10, Gareth R Howell11,12, Hyacinth I Hyacinth13, Kent K C Lloyd14, Kurt R Stenmark15, Manfred Boehm7, Mark L Kahn16, Roderick Corriveau17, Sara Wells18, Timothy J Bussey19.   

Abstract

Clinical investigations have established that vascular-associated medical conditions are significant risk factors for various kinds of dementia. And yet, we are unable to associate certain types of vascular deficiencies with specific cognitive impairments. The reasons for this are many, not the least of which are that most vascular disorders are multi-factorial and the development of vascular dementia in humans is often a multi-year or multi-decade progression. To better study vascular disease and its underlying causes, the National Heart, Lung, and Blood Institute of the National Institutes of Health has invested considerable resources in the development of animal models that recapitulate various aspects of human vascular disease. Many of these models, mainly in the mouse, are based on genetic mutations, frequently using single-gene mutations to examine the role of specific proteins in vascular function. These models could serve as useful tools for understanding the association of specific vascular signaling pathways with specific neurological and cognitive impairments related to dementia. To advance the state of the vascular dementia field and improve the information sharing between the vascular biology and neurobehavioral research communities, National Heart, Lung, and Blood Institute convened a workshop to bring in scientists from these knowledge domains to discuss the potential utility of establishing a comprehensive phenotypic cognitive assessment of a selected set of existing mouse models, representative of the spectrum of vascular disorders, with particular attention focused on age, sex, and rigor and reproducibility. The workshop highlighted the potential of associating well-characterized vascular disease models, with validated cognitive outcomes, that can be used to link specific vascular signaling pathways with specific cognitive and neurobehavioral deficits.

Entities:  

Keywords:  atrophy; blood pressure; mutation; risk factors; vascular dementia

Mesh:

Year:  2022        PMID: 35510549      PMCID: PMC9233038          DOI: 10.1161/ATVBAHA.122.317395

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   10.514


  39 in total

1.  CADASIL: yesterday, today, tomorrow.

Authors:  H Chabriat; A Joutel; E Tournier-Lasserve; M G Bousser
Journal:  Eur J Neurol       Date:  2020-05-22       Impact factor: 6.089

Review 2.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

3.  Methodological Considerations for Optimizing and Validating Behavioral Assays.

Authors:  Stacey J Sukoff Rizzo; Jill L Silverman
Journal:  Curr Protoc Mouse Biol       Date:  2016-12-01

Review 4.  Vascular cognitive impairment.

Authors:  Wiesje M van der Flier; Ingmar Skoog; Julie A Schneider; Leonardo Pantoni; Vincent Mok; Christopher L H Chen; Philip Scheltens
Journal:  Nat Rev Dis Primers       Date:  2018-02-15       Impact factor: 52.329

Review 5.  CADASIL: new advances in basic science and clinical perspectives.

Authors:  Elisa A Ferrante; Cornelia D Cudrici; Manfred Boehm
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

6.  Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice.

Authors:  I Gordon; E Grauer; I Genis; E Sehayek; D M Michaelson
Journal:  Neurosci Lett       Date:  1995-10-13       Impact factor: 3.046

7.  Neurodegeneration in the central nervous system of apoE-deficient mice.

Authors:  E Masliah; M Mallory; N Ge; M Alford; I Veinbergs; A D Roses
Journal:  Exp Neurol       Date:  1995-12       Impact factor: 5.330

8.  "Small Blood Vessels: Big Health Problems?": Scientific Recommendations of the National Institutes of Health Workshop.

Authors:  Francesca Bosetti; Zorina S Galis; Margaret S Bynoe; Marc Charette; Marilyn J Cipolla; Gregory J Del Zoppo; Douglas Gould; Thomas S Hatsukami; Teresa L Z Jones; James I Koenig; Gerard A Lutty; Christine Maric-Bilkan; Troy Stevens; H Eser Tolunay; Walter Koroshetz
Journal:  J Am Heart Assoc       Date:  2016-11-04       Impact factor: 5.501

Review 9.  Update on the Neurobiology of Vascular Cognitive Impairment: From Lab to Clinic.

Authors:  Luisa Vinciguerra; Giuseppe Lanza; Valentina Puglisi; Francesco Fisicaro; Manuela Pennisi; Rita Bella; Mariagiovanna Cantone
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

10.  Role of age and neuroinflammation in the mechanism of cognitive deficits in sickle cell disease.

Authors:  Raven A Hardy; Noor Abi Rached; Jayre A Jones; David R Archer; Hyacinth I Hyacinth
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.